Spirox Starts Using Latera in First U.S. Patients Following Clearance

California-based Spirox announced that it has begun implanting Latera nasal implant in U.S. patients to treat nasal obstruction following FDA clearance of the device.

The device provides ENTs and plastic surgeons with a minimally invasive option to support upper and lower lateral nasal cartilages, helping to prevent nasal valve collapse, the company said.

The company already has tested the product in Germany, where a multi-center study showed that patients that receive Latera experienced a reduction in nasal obstruction symptoms. — Anisa Jibrell